Literature DB >> 9192981

Low specificity of PGP9.5 expression for detection of micrometastatic neuroblastoma.

J Gilbert1, M D Norris, G M Marshall, M Haber.   

Abstract

To determine the specificity of neuroendocrine protein gene product (PGP9.5) gene transcripts for detecting micrometastatic neuroblastoma, we have used a highly sensitive polymerase chain reaction (PCR) technique to evaluate expression of this gene in normal blood and bone marrow. While expression of the tyrosine hydroxylase gene was not detected in any normal sample, low-level PGP9.5 expression was detected in eight out of ten blood and seven of 12 marrow samples. PGP9.5 gene transcripts in normal tissues have the potential to interfere with the detection of micrometastatic neuroblastoma.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9192981      PMCID: PMC2223599          DOI: 10.1038/bjc.1997.303

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  21 in total

1.  Detection of cancer micrometastases in lymph nodes by reverse transcriptase-polymerase chain reaction.

Authors:  M Mori; K Mimori; H Inoue; G F Barnard; K Tsuji; S Nanbara; H Ueo; T Akiyoshi
Journal:  Cancer Res       Date:  1995-08-01       Impact factor: 12.701

2.  Prostate-specific antigen messenger RNA is expressed in non-prostate cells: implications for detection of micrometastases.

Authors:  M R Smith; S Biggar; M Hussain
Journal:  Cancer Res       Date:  1995-06-15       Impact factor: 12.701

3.  Low specificity of cytokeratin 19 reverse transcriptase-polymerase chain reaction analyses for detection of hematogenous lung cancer dissemination.

Authors:  M Krismann; B Todt; J Schröder; D Gareis; K M Müller; S Seeber; J Schütte
Journal:  J Clin Oncol       Date:  1995-11       Impact factor: 44.544

4.  Sensitive detection of occult breast cancer by the reverse-transcriptase polymerase chain reaction.

Authors:  Y H Datta; P T Adams; W R Drobyski; S P Ethier; V H Terry; M S Roth
Journal:  J Clin Oncol       Date:  1994-03       Impact factor: 44.544

5.  Early clinical evaluation of neuroblastoma cell detection by reverse transcriptase-polymerase chain reaction (RT-PCR) for tyrosine hydroxylase mRNA.

Authors:  S A Burchill; F M Bradbury; P Selby; I J Lewis
Journal:  Eur J Cancer       Date:  1995       Impact factor: 9.162

6.  Neuroblastoma cell detection by reverse transcriptase-polymerase chain reaction (RT-PCR) for tyrosine hydroxylase mRNA.

Authors:  S A Burchill; F M Bradbury; B Smith; I J Lewis; P Selby
Journal:  Int J Cancer       Date:  1994-06-01       Impact factor: 7.396

7.  Detection of circulating tumor cells in patients with localized and metastatic prostatic carcinoma: clinical implications.

Authors:  R A Ghossein; H I Scher; W L Gerald; W K Kelly; T Curley; A Amsterdam; Z F Zhang; J Rosai
Journal:  J Clin Oncol       Date:  1995-05       Impact factor: 44.544

8.  Surfactant protein gene expression in metastatic and micrometastatic pulmonary adenocarcinomas and other non-small cell lung carcinomas: detection by reverse transcriptase-polymerase chain reaction.

Authors:  C Betz; T Papadopoulos; J Buchwald; J Dämmrich; H K Müller-Hermelink
Journal:  Cancer Res       Date:  1995-10-01       Impact factor: 12.701

9.  Detection of neuroblastoma cells in bone marrow and peripheral blood at diagnosis by the reverse transcriptase-polymerase chain reaction for tyrosine hydroxylase mRNA.

Authors:  Y Miyajima; K Kato; S Numata; K Kudo; K Horibe
Journal:  Cancer       Date:  1995-06-01       Impact factor: 6.860

10.  The detection of melanoma cells in peripheral blood by reverse transcription-polymerase chain reaction.

Authors:  A J Foss; M J Guille; N L Occleston; P G Hykin; J L Hungerford; S Lightman
Journal:  Br J Cancer       Date:  1995-07       Impact factor: 7.640

View more
  6 in total

Review 1.  Micrometastases in neuroblastoma: are they clinically important?

Authors:  S A Burchill
Journal:  J Clin Pathol       Date:  2004-01       Impact factor: 3.411

2.  Use of tumor-specific gene expression for the differential diagnosis of neuroblastoma from other pediatric small round-cell malignancies.

Authors:  J Gilbert; M Haber; S B Bordow; G M Marshall; M D Norris
Journal:  Am J Pathol       Date:  1999-07       Impact factor: 4.307

Review 3.  Cellular kinetics of neuroblastoma and the role of surgery.

Authors:  Tatsuo Kuroda
Journal:  Pediatr Surg Int       Date:  2011-07-19       Impact factor: 1.827

4.  Consensus criteria for sensitive detection of minimal neuroblastoma cells in bone marrow, blood and stem cell preparations by immunocytology and QRT-PCR: recommendations by the International Neuroblastoma Risk Group Task Force.

Authors:  K Beiske; S A Burchill; I Y Cheung; E Hiyama; R C Seeger; S L Cohn; A D J Pearson; K K Matthay
Journal:  Br J Cancer       Date:  2009-04-28       Impact factor: 7.640

5.  Clinical Significance of Tyrosine Hydroxylase mRNA Transcripts in Peripheral Blood at Diagnosis in Patients with Neuroblastoma.

Authors:  Na Hee Lee; Meong Hi Son; Young Bae Choi; Eunsang Yi; Ji Won Lee; Keon Hee Yoo; Ki Woong Sung; Hong Hoe Koo
Journal:  Cancer Res Treat       Date:  2016-03-24       Impact factor: 4.679

6.  PCR-based amplification of circulating RNAs as prognostic and predictive biomarkers - Focus on neuroblastoma.

Authors:  Sam C Brownhill; Sue A Burchill
Journal:  Pract Lab Med       Date:  2016-04-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.